Company Research Report: TriNetX, LLC
Company Overview
- Name: TriNetX, LLC
- Mission: Connecting the world to improve human health by leveraging real-world data to enhance clinical trial design, streamline operations, refine safety signals, and enrich real-world evidence generation.
- Founded: 2013
- Founders: Not specified in the available data.
- Key People:
- Gadi Lachman, Chief Executive Officer
- Jeff Margolis, Executive Chairman
- Jeffrey Brown, Chief Scientific Officer
- Shields Carstarphen, Chief Commercial Officer
- Jennifer Eagan, Vice President of People
- Michelle Fleming, Chief Marketing Officer
- Chris Fraser, Interim Chief Financial Officer
- Andrew Kopelman, General Counsel
- Steve Kundrot, Chief Technology & Solutions Officer
- Headquarters: 100 Cambridgepark Drive, Suite 501 Cambridge, MA 02140, USA
- Number of Employees: No information is available
- Revenue: No information is available
- Company Recognition: Known for its role in providing real-world data and real-world evidence solutions for trial design, drug development, and clinical research.
Products
- Products Offered:
- TriNetX Platform: An intuitive query builder and platform providing access to millions of de-identified patient records from around the world.
- Real-World Evidence & Data Services: Solutions providing insights into safety, efficacy, and value of treatments through expert evidence strategies.
- Clinical Trial Optimization Tools: Services and platforms to enhance trial design, site selection, and patient recruitment.
- Drug Safety & Pharmacovigilance Solutions: Tools combining data from public sources and electronic health records to improve drug safety signal analysis.
- High-Level Description of Products: TriNetX utilizes a comprehensive suite of data analytics and research services to support drug development and healthcare research by enabling closer access to real-world data and evidence.
- Key Features of Each Product:
- TriNetX Platform: Real-time querying capabilities, advanced analytics for treatment pattern discovery, and patient cohort definition without manual data wrangling.
- Real-World Evidence & Data Services: Leverages global healthcare data for regulatory, clinical, and safety insights.
- Clinical Trial Optimization Tools: Reduces time and cost associated with trial site identification and patient recruitment.
- Drug Safety & Pharmacovigilance Solutions: Integration with harmonized datasets to enhance pharmacovigilance activities.
Recent Developments
- Recent Developments:
- Partnership with Fujitsu: Launched a joint venture to increase Japanese patients' access to life-changing medicines (February 2025).
- ENS Certification in Spain: Achieved high-level certification for healthcare data security standards within its platform (September 2024).
- Recognition on Fortune Impact 20 List: Named for pioneering advancements in clinical trial diversity (December 2023).
- New Products or Features: No specific new products or features mentioned.
- New Partnerships: TriNetX has partnered with Fujitsu to enhance access to medicines and clinical trial acceleration in Japan.
This report presents an overview of TriNetX, emphasizing its role in the healthcare and life sciences domain through real-world data insights. The company's innovations in trial design and evidence generation are driven by a dedicated leadership team and strategic partnerships aimed at improving global patient outcomes.
